Southern RNA’s facilities support RNA development from research to GMP manufacturing. Our infrastructure ensures seamless workflows, reducing risk and accelerating timelines. We combine expertise, advanced equipment, and quality systems to deliver reliable, regulatory-ready RNA solutions.
Southern RNA’s labs feature advanced transcription systems, purification platforms, and analytical tools. Dedicated R&D, testing, and GMP spaces allow experiments and manufacturing to proceed without quality compromise.
Our R&D labs have advanced tools for RNA design, method development, and experimentation. Key equipment includes transcription systems, liquid handlers, PCR machines, and integrity analysers, allowing reproducible workflows and rapid optimisation of RNA constructs.
Our GMP-aligned labs include HPLC/FPLC systems, ultrafiltration units, and cold storage. Analytical suites support testing, while laminar flow hoods ensure GMP compliance, guaranteeing high-quality RNA production.
Quality is central to Southern RNA. Our Quality Management System supports GMP operations and early-phase clinical manufacturing. From raw material qualification to final product release, every step follows documented procedures and risk assessments to ensure consistency and patient safety.
Compliance is embedded in our workflows, not just a final checkpoint. We maintain documentation systems, change management processes, and analytical verification to support regulatory submissions. By aligning quality oversight with execution, we help clients progress confidently from research to clinical supply.
Our facilities and processes are designed with regulatory compliance in mind, supporting first-in-human studies and early-phase trials. Every batch is documented with audit-ready records, validated methods, and controlled change management. This regulatory readiness reduces risk for sponsors and ensures smooth interactions with health authorities.
